Contaminants in generic drugs may cause long-term harm to DNA: B.C. researcher
Contaminants in some generic medications used to treat heart disease, diabetes and other common conditions could damage DNA, affect basic cell functions and increase the risk of cancer, suggests a study from the University of British Columbia.
Corey Nislow, a professor in the faculty of pharmaceutical sciences, said the findings from his lab on nitrosamines, impurities that are considered probable carcinogens, suggest overseas facilities that manufacture cheaper generic drugs in high volumes require strict regulation and enforcement to ensure they're complying with standards.
Health Canada was among regulators in several countries that announced recalls in 2018 on medications containing the active ingredient Valsartan, which was found to contain a nitrosamine impurity before at least six other associated toxins were later detected in some other drugs made by different manufacturers.
Valsartan, sold under several trade names, is used to treat heart failure and high blood pressure.
While Health Canada said there is no immediate health risk associated with the use of medications containing low levels of a nitrosamine impurity, Nislow said an estimated 50 million prescriptions were written for so-called sartans in Canada alone since nitrosamines were detected in many types of generics in 2012.
It's not known if patients who took the drug for six years before the recalls could experience long-term effects, he said.
In order to better understand the impact of nitrosamines, researchers at Nislow's lab studied them in yeast, which shares about half of its genes with humans, making it a good substitute for human cells in experiments that could later lead to studies in people.
Researchers started with 4,800 strains of yeast and added high doses of nitrosamines to the entire batch. Then they deleted each gene, one at a time, to try and determine how the toxin would affect its growth.
The strains that were missing genes that repair DNA and the machinery that makes cell proteins grew five to 50 times slower, Nislow said.
A study outlining the results was published this week in the journal Scientific Reports.
“The one single take-home message is that people have been taking medicines with this contaminant for a long time and we don't know the long-term consequences,” he said. “Now that we can follow up on those genes and figure out exactly why they're needed, we could get clues as to how we can help people who have been taking those contaminants for six years without knowing it.”
Damage to DNA can cause mutations that could be inherited and if they're unrepaired by the body, could lead to cancer, Nislow said.
Health Canada said it is collaborating with six other international regulators including the U.S. Food and Drug Administration, the European Medicines Agency and Japan's Ministry of Health to better understand the global issue of nitrosamines.
The agency said it sent a letter last December to drug manufacturers to conduct detailed evaluations of their manufacturing procedures for the potential presence of nitrosamines.
It said patients should talk to their health provider before stopping a prescribed medication and that not treating a condition may pose a greater risk than the potential exposure to a nitrosamine impurity.
Most of the inspections of facilities that make so-called active pharmaceutical ingredients are based on a self-reporting system, potentially putting consumers at risk, Nislow said.
“This particular case, with this particular contaminant, we think arose when they changed their manufacturing process to a cheaper process and no one was informed. And because no one was looking for this contaminant, it went unreported and undetected for nearly a decade.”
Health Canada, the U.S. Food and Drug Administration and the European Medicines Agency are among regulators that have been testing drugs that are shipped from overseas.
However, he said that's not good enough.
“In order to effect a long-lasting change, they should be testing at the point of manufacture, which is overseas.”
Many of the drugs are made in China and India, where costs are lower, Nislow said.
“But I wonder if this is an elaborate game of Whack-A-Mole, where we're chasing after the last quality control failure.
“If we want our drug prices low and we're willing to source our materials from overseas and we want them to be safe, we have to go back to 20 years ago when the enforcement mechanisms were more consequential.”
Ultimately, consumers may need to demand better quality control for generic drugs, Nislow said.
This report by The Canadian Press was first published June 15, 2021.
CTVNews.ca Top Stories
NDP motion regarding Palestinian statehood passes after major Liberal alterations
A motion from the federal New Democrats initially calling on Canada to recognize the 'State of Palestine' passed amid widespread acrimony on Monday, after the Liberals drastically altered its wording to see the government simply work towards that aim as part of a two-state solution.
'He didn't want to die': Family of Calgary man killed in standoff speaks out
Family of a Calgary man killed after a 30-hour standoff with police last week are speaking out, sharing details of the tense and heart-wrenching experience.
Toronto family doctor who called patient's body 'perfect' suspended for 3 months: tribunal
A family doctor in Toronto has been suspended for three months after a disciplinary tribunal found that he failed to follow proper protocols while examining a patient's breasts and made inappropriate comments about her body.
Ohio mom who left toddler alone 10 days when she went on vacation pleads guilty to aggravated murder
An Ohio mother whose 16-month-old daughter died after being left home alone in a playpen for 10 days last summer while she went on vacation was sentenced Monday to life in prison with no chance of parole.
Retired teacher pleads guilty to paying for sex with 15-year-old in Collingwood, Ont.
In a Barrie courtroom on Monday, a retired high school teacher from the Niagara Region pleaded guilty to sexual touching and obtaining sexual services from a 15-year-old boy in Collingwood in 2021.
Hertz CEO out following electric car 'horror show'
The company, which announced in January it was selling 20,000 of the electric vehicles in its fleet, or about a third of the EVs it owned, is now replacing the CEO who helped build up that fleet, giving it the company’s fifth boss in just four years.
5 charged in Calgary kidnappings that targeted women
Calgary police have charged five men in a pair of kidnappings last year that targeted innocent victims.
Demand soars for solar eclipse glasses in Canada. Are they worth buying?
The demand for total solar eclipse glasses used to safely view the rare celestial event has been ramping up as sellers, along with astronomy and eye-care experts in Canada, warn that viewing the eclipse with the naked eye is dangerous.
Canadian commander of volunteer fighter group dies in Ukraine
A Canadian-born commander of the so-called Norman Brigade, a volunteer fighting group in Ukraine, has died.